Mumbai, Feb. 13 -- The toll in the incidence of Guillain-Barre Syndrome (GBS) -- an autoimmune disorder where the body's immune system attacks the nervous system- rose to eight in Maharashtra on ...

MUMBAI: A 53-year-old man has died of Guillain-Barre Syndrome (GBS) at a hospital in Mumbai, the first fatality here due to the nerve disorder, officials said on Wednesday. The patient, a resident ...

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are diseases of the nervous system. They’re not the same, but they do have a lot of similarities. Both MS and GBS are autoimmune diseases.

He sees this moment as a promising one when there is potential to make advances in the treatment of GBS after decades without any significant developments. “GBS is an acute debilitating neuromuscular ...

T he new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers ...

Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease ...

Global study: COVID-19 and adenoviral vaccines tied to GBS risk, not mRNA vaccines Large-scale study in a population covering more than 230 million people sheds light on the relationship between ...

MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained ...

BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...